Literature DB >> 18081653

Review article: New developments in colonic imaging.

F J C van den Broek1, P Fockens, E Dekker.   

Abstract

BACKGROUND: Colonoscopic detection and removal of neoplasia from the colorectum prevent the development of colorectal cancer. Sporadic adenomas and neoplasia associated with ulcerative colitis are frequently missed during colonoscopy, as a result of which, interval cancers might develop. AIM: To review new developments in colonoscopic imaging concerning the detection of neoplasia.
METHODS: Medical databases were searched for relevant publications, dealing with advanced endoscopic imaging techniques during colonoscopy.
RESULTS: Pancolonic chromoendoscopy has shown to increase the detection of sporadic adenomas and ulcerative colitis associated neoplasia, at the expense of longer examination times. As chromoendoscopy is labour intensive and time-consuming, its widespread use has been hampered. Narrow band imaging is a novel endoscopic imaging technique, which enhances mucosal and vascular details. Recent studies indicate that narrow band imaging has a high yield for neoplasia; however, no improvement compared to standard colonoscopy has been demonstrated. Autofluorescence imaging is another new technique for which blue endoscopic light is used to induce mucosal autofluorescence. So far, preliminary results have shown promising results of autofluorescence imaging for neoplasia detection.
CONCLUSION: Whether chromoendoscopy or novel advanced imaging techniques will change current colonoscopic practice depends on results of future studies comparing these different colonoscopic techniques.

Entities:  

Mesh:

Year:  2007        PMID: 18081653     DOI: 10.1111/j.1365-2036.2007.03494.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

Review 1.  Emerging technologies in upper gastrointestinal endoscopy and celiac disease.

Authors:  Giovanni Cammarota; Paolo Fedeli; Antonio Gasbarrini
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-11

Review 2.  Endoscopic tools for the diagnosis and evaluation of celiac disease.

Authors:  Gianluca Ianiro; Antonio Gasbarrini; Giovanni Cammarota
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

3.  Hyperspectral imaging fluorescence excitation scanning for colon cancer detection.

Authors:  Silas J Leavesley; Mikayla Walters; Carmen Lopez; Thomas Baker; Peter F Favreau; Thomas C Rich; Paul F Rider; Carole W Boudreaux
Journal:  J Biomed Opt       Date:  2016-10-01       Impact factor: 3.170

4.  Phthalocyanine-peptide conjugates for epidermal growth factor receptor targeting.

Authors:  Benson G Ongarora; Krystal R Fontenot; Xiaoke Hu; Inder Sehgal; Seetharama D Satyanarayana-Jois; M Graça H Vicente
Journal:  J Med Chem       Date:  2012-04-18       Impact factor: 7.446

5.  A potential of peanut agglutinin-immobilized fluorescent nanospheres as a safe candidate of diagnostic drugs for colonoscopy.

Authors:  Shinji Sakuma; Makoto Kataoka; Haruki Higashino; Takanori Yano; Yoshie Masaoka; Shinji Yamashita; Ken-Ichiro Hiwatari; Hiroyuki Tachikawa; Ryoji Kimura; Kunio Nakamura; Hironori Kumagai; John C Gore; Wellington Pham
Journal:  Eur J Pharm Sci       Date:  2011-01-07       Impact factor: 4.384

6.  Synthesis and biological investigations of a ZnPc-antiCEA bioconjugate for imaging of colorectal cancer.

Authors:  Inder Sehgal; Hairong Li; Benson Ongarora; Daniel Devillier; M Graça H Vicente
Journal:  J Porphyr Phthalocyanines       Date:  2013-01-01       Impact factor: 1.811

7.  Quality colonoscopy: a matter of time, technique or technology?

Authors:  Robert H Lee
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

8.  Peptide ligands for targeting the extracellular domain of EGFR: Comparison between linear and cyclic peptides.

Authors:  Tyrslai M Williams; Rushikesh Sable; Sitanshu Singh; Maria Graca H Vicente; Seetharama D Jois
Journal:  Chem Biol Drug Des       Date:  2017-11-16       Impact factor: 2.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.